Sequential Matrix Metalloproteinase-1 Expression Triggered by Infiltrating Monocytic Lineage Cells Modulates Pathophysiological Aspects of Human Nonalcoholic Steatohepatitis

References

• Younossi ZM, Loomba R, Rinella ME, et al. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2018;68:361–371. doi:10.1002/hep.29724
   PubMed Web of Science ®Google Scholar
• Okazaki I, Noro T, Tsutsui N, et al. Fibrogenesis and carcinogenesis in nonalcoholic steatohepatitis (NASH): involvement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs). Cancers. 2014;6:1220–1255. doi:10.3390/cancers6031220
   Web of Science ®Google Scholar
• Okazaki I, Ninomiya Y, Friedman SL, Tanikawa K, eds, Extracellular Matrix and the Liver. Approach to Gene Therapy. London, New York: Academic Press, Amsterdam, Boston; 2003:1–467.
   Google Scholar
• Okazaki I, Nabeshima K. Introduction: MMPs, ADAMs/ADAMTSs research products to achieve big dream. Anticancer Agents Med Chem. 2012;12:688–706. doi:10.2174/187152012802650200
   PubMed Web of Science ®Google Scholar
• Okazaki I, Maruyama K. Collagenase activity in experimental hepatic fibrosis. Nature. 1974;252:49–50. doi:10.1038/252049a0
   PubMed Web of Science ®Google Scholar
• Watanabe T, Niioka M, Hozawa S, et al. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol. 2000;33:224–235. doi:10.1016/S0168-8278(00)80363-3
   PubMed Web of Science ®Google Scholar
• Watanabe T, Niioka M, Ishikawa A, et al. Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol. 2001;35:465–473. doi:10.1016/S0168-8278(01)00177-5
   Web of Science ®Google Scholar
• Higashiyama R, Inagaki Y, Hong YY, et al. Bone marrow-derived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice. Hepatology. 2007;45:213–222. doi:10.1002/hep.21477
   PubMed Web of Science ®Google Scholar
• Endo H, Niioka M, Sugioka Y, et al. Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats. Pathobiology. 2011;78:239–252. doi:10.1159/000328841
   Web of Science ®Google Scholar
• Yokomori H, Inagaki Y, Ando W, et al. Spatiotemporal expression of metalloproteinase-1 in progression of nonalcoholic steatohepatitis. J Mod Hum Pathol. 2016;1:11–20. doi:10.14312/2397-6845.2016-3
   Google Scholar
• Yokomori H, Ando W, Oda M, Inagaki Y, Okazaki I. Hepatic progenitor cell expansion in early-stage nonalcoholic steatohepatitis: evidence from immunohistochemistry and immunoelectron microscopy of matrix metalloproteinase-1. Med Mol Morphol. 2017;50:238–242. doi:10.1007/.s00795-017-0162-y
   Web of Science ®Google Scholar
• Ando W, Yokomori H, Tsutsui N, et al. Serum matrix metalloproteinase-1 represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis. Clin Mol Hepatol. 2018;24:61–76. doi:10.3350/cmh.2017.0030
   Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328–357. doi:10.1002/hep.29367
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Loomba R, Anstee QM, et al. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018;68:349–360. doi:10.1002/hep.29721
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62-S69. doi:10.2337/dc11-S062
   PubMed Web of Science ®Google Scholar
• The Japanese Task Force Committee for Diagnosis Criteria of Metabolic Syndrome. Definition and diagnosis criteria of metabolic syndrome. J Jap Inter Med Ass. 2005;94:794–809.
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497. doi:10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Morini S, Carotti S, Carpino G, et al. GFAP expression in the liver as an early marker of stellate cells activation. It J Anat Embryol. 2005;110:193–2007.
   PubMedGoogle Scholar
• Yang L, Jung Y, Omenetti A, et al. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells. 2008;26:2104–2113. doi:10.1634/stemcells.2008-0115
   PubMed Web of Science ®Google Scholar
• Shibata S, Iseda T, Mitsuhashi T, et al. Large-area fluorescence and electron microscopic correlative imaging with multibeam scanning electron microscopy. Front Neural Circuits. 2019;13:29. doi:10.3389/fncir2019.00029
   Web of Science ®Google Scholar
• Sugioka Y, Watanabe T, Inagaki Y, et al. c-JUN NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line. Int J Cancer. 2004;109:867–874. doi:10.1002/ijc.20095
   Web of Science ®Google Scholar
• Yanagawa T, Sumiyoshi H, Higashi K, et al. Identification of a novel bone marrow cell-derived accelerator of fibrotic liver regeneration through mobilization of hepatic progenitor cells in mice. Stem Cells. 2019;37:89–101. doi:10.1002/stem.2916
   Web of Science ®Google Scholar
• Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–637. doi:10.1016/s0092-8674(02)00754-7
   PubMed Web of Science ®Google Scholar
• Bihari C, Anand L, Rooge S, et al. Bone marrow stem cells and their niche components are adversely affected in advanced cirrhosis of the liver. Hepatology. 2016;64:1273–1288. doi:10.1002/hep.28754
   Web of Science ®Google Scholar
• Boulter L, Govaere O, Bird TG, et al. Macrophage derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012;18:572–579. doi:10.1038/nm.2667
   PubMed Web of Science ®Google Scholar
• Pollard JW. Tropic macrophages in development and disease. Nat Rev Immunol. 2009;9:259–270. doi:10.1038/nri2528
   PubMed Web of Science ®Google Scholar
• Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci. 2005;118(Pt 10):2325–2340. doi:10.1242/jcs.02360
   PubMed Web of Science ®Google Scholar
• Iimuro Y, Nishio T, Morimoto T, et al. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology. 2003;124:445–458. doi:10.1053/gast.2003.50063
   PubMed Web of Science ®Google Scholar
• Siller-Lόpez F, Sandoval A, Salgado S, et al. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology. 2004;126:1122–1133. doi:10.1053/j.gastro.2003.12.045
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem. 2007;282(32):23337–23347. doi:10.1074/jbc.M700194200
   PubMed Web of Science ®Google Scholar
• Syn W-K, Jung Y, Omenetti A, et al. Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in non-alcoholic fatty liver disease. Gastroenterology. 2009;137:1478–1488. doi:10.1053/j.gastro.2009.06.051
   PubMed Web of Science ®Google Scholar
• Zhao Y-L, Zhu R-T, Sun Y-L. Epithelial-mesenchymal transition in liver fibrosis (Review). Biomed Rep. 2016;4:269–274. doi:10.3892/br.2016.578
   PubMed Web of Science ®Google Scholar
• Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17:548–558. doi:10.1016/j.ceb.2005.08.001
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798–808. doi:10.1016/j.jhep.2016.05.007
   PubMed Web of Science ®Google Scholar
• Okazaki I, Wada N, Nakano M, et al. Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas. Hepatology. 1997;25:580–584. doi:10.1002/hep.510250315
   Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52–67. doi:10.1016/j.cell.2010.03.015
   PubMed Web of Science ®Google Scholar
• Ma F, Zhang L, Li M, Zhang Y, Zhang J, Guo B. Mir-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. J Exp Clin Cancer Res. 2017;36:158. doi:10.1186/s13046-017-0630-1
   PubMed Web of Science ®Google Scholar
• Ma H, Cai H, Zhang Y, et al. Membrane palmitoylated protein 3 promotes hepatocellular carcinoma cell migration and invasion via up-regulating matrix metalloproteinase 1. Cancer Lett. 2014;344:74–81. doi:10.1016/j.canlet.2013.10.017
   Web of Science ®Google Scholar
• Kim E, Kim D, Lee J-S, et al. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP-1 axis. Hepatology. 2018;67:2287–2301. doi:10.1002/hep.29738
   Web of Science ®Google Scholar
• Sauter W, Rosenberger A, Beckmann L, et al. Matrix metalloproteinase 1 (MMP-1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1127–1135. doi:10.1158/1055-9965.EPI-07-2840
   PubMed Web of Science ®Google Scholar
• Saito R, Miki Y, Ishida N, et al. The significance of MMP-1 in EGFR-TKI-resistant lung adenocarcinoma: potential for therapeutic targeting. Int J Mol Sci. 2018;19:609. doi:10.3390/ijms.19020609
   Web of Science ®Google Scholar
• Lee Y-S, Kim S-Y, Ko E, et al. Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017;7:3710. doi:10.1038/s41598-017-03389-2
   PubMed Web of Science ®Google Scholar
• Hohenester S, Christiansen S, Nagel J, et al. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation and fibrosis. Am J Physiol Gastrointest Liver Physiol. 2018;315:G329-G338. doi:10.1152/ajpgi.00044.2018
   PubMed Web of Science ®Google Scholar
• Balbin M, Fueyo A, Knauper V, et al. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem. 2001;276:10253–10262. doi:10.1074/jbc.M009586200
   PubMedGoogle Scholar
• Nevzorova YA, Boyer-Diaz Z, Cubero FJ, Gracia-Sancho J. Animal models for liver disease - a practical approach for translational research. J Hepatol. 2020. doi:10.1016/j.jhep.2020.04.011
   Web of Science ®Google Scholar
• Ouchi R, Togo S, Kimura M, et al. Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab. 2019;30:374–384.e6. doi:10.1016/j.cmet.2019.05.007
   Web of Science ®Google Scholar
• Kim K-H, Jung J-Y, Son ED, Shin DW, Noh M, Lee TR. miR-526b targets 3ʹUTR of MMP-1 mRNA. Exp Mol Med. 2015;47:e178. doi:10.38/emm.2015.52
   PubMed Web of Science ®Google Scholar
• Li W-D, Zhou D-M, Sun -L-L, et al. LncRNA WTAPP1 promotes migration and angiogenesis of endothelial progenitor cells via MMP-1 through microRNA 3,120 and AKT/P13K/autophagy pathways. Stem Cells. 2018. doi:10.1002/stem.2904
   Google Scholar